Interleukin-18-binding protein (IL18BP) regulates the activity of IL-18, which has been shown to be higher in breast carcinoma tissue compared to tissue from patients with benign breast disease (Srabovic et al. 2011). The gene discussed is IL18; the disease is breast fibrocystic disease.